VEA Vice Chair Nell Minow is quoted in this article about pharma companies’ reluctance to split the CEO and chair roles.

“You don’t get to be a CEO by wanting to report to anybody, which is why it’s important to have somebody overseeing [the CEO],” said Nell Minow, a corporate governance expert who serves as vice chair of the institutional investment consulting group ValueEdge Advisors.

via Give up board chairmanship? No thanks, US big pharma CEOs say | BioPharma Dive